VARIABILITY AMONG RETINA SPECIALISTS IN EVALUATING FLUORESCEIN ANGIOGRAMS OF PATIENTS WITH NEOVASCULAR AGERELATED MACULAR DEGENERATION
Authors:
- Shiri Zayit-SoudrySZShiri Zayit-Soudry
- Meirav AlfasiMAMeirav Alfasi
- Michaella GoldsteinMGMichaella Goldstein
- Joseph MoisseievJMJoseph Moisseiev
- Ruth Axer-SiegelRARuth Axer-Siegel
- Ayala PollackAPAyala Pollack
- Yuval YassurYYYuval Yassur
- Anat LoewensteinALAnat Loewenstein
- 1 July 2007
- journal article
- Published by Wolters Kluwer Health in Retina
- Vol. 27 (6) , 798-803
Abstract
To determine the rate of agreement among five retina specialists in classifying various angiographic features of subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), as evaluated on printed digital fluorescein angiogram (FA) frames, as well as determination of eligibility for photodynamic treatment (PDT) according to established guidelines. Ninety-two digital FAs demonstrating subfoveal CNV secondary to AMD were evaluated independently by five retina specialists. The pattern of classic component could be classified as no classic component, minimally classic, predominantly classic, or classic only. Each grader was asked to determine eligibility of each case to PDT according to established treatment guidelines, national health insurance guidelines, and one’s own personal judgment. The κ coefficient of concordance calculated for all five observers regarding CNV localization was 0.285, indicating fair overall agreement, and was 0.295, indicating fair agreement, regarding classification of leakage pattern. The κ coefficient of agreement calculated for all five graders regarding eligibility for treatment according to established international guidelines, national health insurance, and each grader’s own personal judgment was 0.163, 0.33, and 0.164, respectively, indicating slight to fair overall agreement. Considerable variability may exist among retina specialists interpreting FAs and should be considered in the assessment of treatment guidelines.Keywords
This publication has 16 references indexed in Scilit:
- ENHANCED EFFICACY ASSOCIATED WITH EARLY TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB SODIUMRetina, 2005
- GUIDELINES FOR USING VERTEPORFIN (VISUDYNE) IN PHOTODYNAMIC THERAPY FOR CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES: UPDATERetina, 2005
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Verteporfin Therapy of Subfoveal Choroidal Neovascularization in Patients With Age-Related Macular DegenerationArchives of Ophthalmology (1950), 2002
- Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2American Journal of Ophthalmology, 2001
- Choroidal neovascular membranes: reproducibility of angiographic interpretationAmerican Journal of Ophthalmology, 2000
- Laser Photocoagulation for Juxtafoveal Choroidal NeovascularizationArchives of Ophthalmology (1950), 1994
- Visual Outcome After Laser Photocoagulation for Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1994
- Subfoveal Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991
- Argon Laser Photocoagulation for Neovascular MaculopathyArchives of Ophthalmology (1950), 1991